Parkinsons Recovery with Robert Rogers: Can Probiotics Help Parkinson's GI Symptoms
by Martha Carlin December 22, 2023
Martha Carlin, CEO and Founder of The BioCollective, Citizen Scientist and wife of John Carlin, an 18 year "veteran" of Parkinson's Disease discusses their journey together to find supportive therapies for better quality of life and her company's development of the probiotic BiotiQuest Sugar Shift. Martha will discuss her Company's research in the Parkinson's Microbiome, emerging research in gut health and constipation as an early indicator of Parkinson's, and the foundational science behind the Sugar Shift formula. The BiotiQuest Sugar Shift formula was designed to make mannitol in the gut with eight strains of probiotic bacteria the work together to convert Glucose and Fructose in the body in to mannitol.
Behind closed eyes, the brain is carrying out a carefully coordinated night shift. And research into the microbiome raises an intriguing question: how might the activity in our gut influence the sleep that gives this work its opportunity?
When discussing gut health, the conversation usually centers on the microbiome. While balancing gut bacteria remains essential, cutting-edge science highlights another critical component of cellular health: the glycocalyx.
When discussing chronic neurological conditions like Parkinson’s disease, conventional medicine frequently focuses on a single narrative: dopamine depletion. While managing neurotransmitters remains a core part of traditional care, emerging physical chemistry and microbiome research reveal a far broader picture.